MENU
+Compare
XTNT
Stock ticker: ASE
AS OF
Jan 17 closing price
Price
$0.52
Change
-$0.00 (-0.00%)
Capitalization
152.31M

XTNT Xtant Medical Holdings Forecast, Technical & Fundamental Analysis

a manufacturer of surgical products

XTNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for XTNT with price predictions
Jan 08, 2025

Momentum Indicator for XTNT turns positive, indicating new upward trend

XTNT saw its Momentum Indicator move above the 0 level on December 23, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 98 similar instances where the indicator turned positive. In of the 98 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

XTNT moved above its 50-day moving average on January 02, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for XTNT crossed bullishly above the 50-day moving average on January 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where XTNT advanced for three days, in of 214 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for XTNT moved out of overbought territory on January 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 43 cases where XTNT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XTNT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XTNT broke above its upper Bollinger Band on January 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for XTNT entered a downward trend on December 26, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XTNT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.452) is normal, around the industry mean (23.424). P/E Ratio (51.500) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.576) is also within normal values, averaging (41.167).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XTNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
XTNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XTNT is expected to report earnings to fall 64.75% to -1 cents per share on March 11

Xtant Medical Holdings XTNT Stock Earnings Reports
Q4'24
Est.
$-0.01
Q3'24
Missed
by $0.02
Q2'24
Missed
by $0.01
Q1'24
Missed
by $0.01
Q4'23
Est.
$-0.03
The last earnings report on November 12 showed earnings per share of -3 cents, missing the estimate of -1 cents. With 27.93K shares outstanding, the current market capitalization sits at 152.31M.
A.I. Advisor
published General Information

General Information

a manufacturer of surgical products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
664 Cruiser Lane
Phone
+1 406 388-0480
Employees
135
Web
http://www.xtantmedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSAWX19.330.17
+0.89%
Morgan Stanley Inst Asia Opp C
ABSAX22.980.14
+0.61%
American Beacon Small Cp Val A
CVMRX17.240.09
+0.52%
Calvert Emerging Markets Equity R6
RYCEX79.790.24
+0.30%
Rydex Europe 1.25x Strategy C
MSGGX13.58N/A
N/A
Meridian Small Cap Growth Legacy

XTNT and Stocks

Correlation & Price change

A.I.dvisor tells us that XTNT and OSUR have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XTNT and OSUR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTNT
1D Price
Change %
XTNT100%
+0.58%
OSUR - XTNT
28%
Poorly correlated
-1.88%
ACRS - XTNT
25%
Poorly correlated
+2.39%
CLPT - XTNT
25%
Poorly correlated
+0.53%
OM - XTNT
24%
Poorly correlated
-3.45%
QIPT - XTNT
23%
Poorly correlated
+3.07%
More